BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30008322)

  • 21. ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation.
    Gu Y; Chen Y; Wei L; Wu S; Shen K; Liu C; Dong Y; Zhao Y; Zhang Y; Zhang C; Zheng W; He J; Wang Y; Li Y; Zhao X; Wang H; Tan J; Wang L; Zhou Q; Xie G; Liang H; Ou J
    Nat Commun; 2021 Nov; 12(1):6711. PubMed ID: 34795238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of YAP by NCTD disrupts NSCLC progression.
    Guo J; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Li X; Xi S
    Oncotarget; 2017 Jan; 8(2):2307-2319. PubMed ID: 27903989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis.
    Zhou B; Flodby P; Luo J; Castillo DR; Liu Y; Yu FX; McConnell A; Varghese B; Li G; Chimge NO; Sunohara M; Koss MN; Elatre W; Conti P; Liebler JM; Yang C; Marconett CN; Laird-Offringa IA; Minoo P; Guan K; Stripp BR; Crandall ED; Borok Z
    J Clin Invest; 2018 Mar; 128(3):970-984. PubMed ID: 29400695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
    Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
    Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
    Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY
    PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents.
    Hata S; Hirayama J; Kajiho H; Nakagawa K; Hata Y; Katada T; Furutani-Seiki M; Nishina H
    J Biol Chem; 2012 Jun; 287(26):22089-98. PubMed ID: 22544757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
    Georgescu MM; Gagea M; Cote G
    Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
    Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
    Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
    Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
    Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP-mediated induction of monoacylglycerol lipase restrains oncogenic transformation.
    Tang ED; Wang CY
    Cell Signal; 2015 Apr; 27(4):836-40. PubMed ID: 25636199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YAP Nuclear Localization in the Absence of Cell-Cell Contact Is Mediated by a Filamentous Actin-dependent, Myosin II- and Phospho-YAP-independent Pathway during Extracellular Matrix Mechanosensing.
    Das A; Fischer RS; Pan D; Waterman CM
    J Biol Chem; 2016 Mar; 291(12):6096-110. PubMed ID: 26757814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting IRF3 as a YAP agonist therapy against gastric cancer.
    Jiao S; Guan J; Chen M; Wang W; Li C; Wang Y; Cheng Y; Zhou Z
    J Exp Med; 2018 Feb; 215(2):699-718. PubMed ID: 29339449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.